hydroxyindoleacetic acid has been researched along with Multiple Endocrine Neoplasia Type 1 in 3 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 7.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| "To assess whether serum histamine, chromogranin A or serotonin and urinary N-methylimidazoleacetic acid or 5-hydroxyindoleacetic acid correlate with advanced enterochromaffin cell changes or gastric carcinoids in patients with gastrinomas." | 3.71 | Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. ( Asgharian, B; Bashir, S; Bordi, C; Crafa, P; Entsuah, LK; Ferraro, G; Gibril, F; Jensen, RT; Ojeaburu, JV, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashir, S | 1 |
| Gibril, F | 1 |
| Ojeaburu, JV | 1 |
| Asgharian, B | 1 |
| Entsuah, LK | 1 |
| Ferraro, G | 1 |
| Crafa, P | 1 |
| Bordi, C | 1 |
| Jensen, RT | 1 |
| PASSERI, M | 1 |
| Baudin, E | 1 |
| Bidart, JM | 1 |
| Rougier, P | 1 |
| Lazar, V | 1 |
| Ruffié, P | 1 |
| Ropers, J | 1 |
| Ducreux, M | 1 |
| Troalen, F | 1 |
| Sabourin, JC | 1 |
| Comoy, E | 1 |
| Lasser, P | 1 |
| DeBaere, T | 1 |
| Schlumberger, M | 1 |
3 other studies available for hydroxyindoleacetic acid and Multiple Endocrine Neoplasia Type 1
| Article | Year |
|---|---|
Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoid Tumor; Chromogranin A; Chromogr | 2002 |
[On the urinary elimination of 5-hydroxyindo-lacetic acid in man. I. Behavior of the urinary elimination of 5-hydroxyindolacetic acid after serotonin loading by intramuscular route in healthy and hepatopathic subjects].
Topics: Hydroxyindoleacetic Acid; Indoleacetic Acids; Multiple Endocrine Neoplasia Type 1; Serotonin | 1961 |
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
Topics: Adult; Aged; Calcitonin; Chorionic Gonadotropin, beta Subunit, Human; Female; Hormones; Humans; Hydr | 1999 |